RxDoctor Payments DataLook up a doctor →

Guy Foster, MD

Pulmonary Disease · Carson City, NVNPI 1871674861

Payments from drug & device makers

$16,212in general payments, 2019–2025

Across 926 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$3K
  • AstraZeneca$2K
  • Boehringer Ingelheim$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Sanofi$1K
  • Mylan Specialty L.p.$960
  • plus $6K from 43 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK235$3,353
AstraZeneca87$1,842
Boehringer Ingelheim105$1,660
Regeneron Healthcare Solutions, Inc.71$1,370
Sanofi50$1,133
Mylan Specialty L.p.56$960
United Therapeutics Corporation27$543
Baxter Healthcare30$458
Insmed, Inc.23$429
Grifols USA, LLC20$408
Takeda Pharmaceuticals U.S.A., Inc.23$405
Harmony Biosciences LLC20$403
Pfizer14$273
Actelion Pharmaceuticals US, Inc.13$268
Axsome Therapeutics, Inc.11$238
Mallinckrodt Hospital Products Inc.19$233
Viatris Specialty LLC9$186
Sunovion Pharmaceuticals Inc.15$178
Teva Pharmaceuticals USA, Inc.9$172
Bayer8$141
Sanofi-aventis U.S. LLC2$123
Amgen(2 entities)5$104
Genentech USA, Inc.6$96
Electromed, Inc.7$95
Paratek Pharmaceuticals, Inc.5$89
Verona Pharma, Inc.4$87
Johnson & Johnson(2 entities)5$86
Merck3$77
Advanced Respiratory, Inc5$75
E.r. Squibb & Sons, L.L.C.4$69
Novartis4$64
Shire North American Group Inc3$61
Resmed Corp3$52
Fisher & Paykel Healthcare Inc3$52
Jazz Pharmaceuticals Inc.2$50
Avadel CNS Pharmaceuticals, LLC2$49
Veran Medical Technologies, Inc.3$41
Philips North America LLC2$36
AbbVie2$33
Tactile Systems Technology Inc1$32
La Jolla Pharmaceutical Company1$32
Lilly USA, LLC2$28
Medtronic1$26
Vanda Pharmaceuticals Inc.1$24
Inspire Medical Systems, Inc.1$22
Eisai Inc.1$21
Breas Medical, Inc.1$15
Itamar Medical Inc1$12
3b Medical, Inc.1$7

How this compares

$16,212 in reported general payments places this provider in the 80th percentile of 84 pulmonary disease providers in Nevada.

See all pulmonary disease providers in Nevada →

Medicare billing

Part B allowed, 2024
$442,080
Medicare patients
1,511
Services billed
3,887

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Carson City

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →